Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study.
Karin BengtssonHelena Forsblad-d'EliaElisabeth LieEva KlingbergMats DehlinSofia ExarchouUlf LindströmJohan AsklingLennart T H JacobssonPublished in: Arthritis research & therapy (2017)
Patients with AS, PsA and uSpA are at increased risk for ACS and stroke events, which emphasizes the importance of identification of and intervention against cardiovascular risk factors in SpA patients. Increased alertness for VTE is warranted in patients with SpA.
Keyphrases
- ankylosing spondylitis
- cardiovascular events
- cardiovascular risk factors
- disease activity
- cardiovascular disease
- rheumatoid arthritis
- coronary artery disease
- end stage renal disease
- prostate cancer
- randomized controlled trial
- newly diagnosed
- ejection fraction
- venous thromboembolism
- acute coronary syndrome
- metabolic syndrome
- atrial fibrillation
- prognostic factors
- systemic lupus erythematosus
- patient reported outcomes
- blood brain barrier
- brain injury
- bioinformatics analysis